FDA calls for SCS pay reform in evidence to the Senior Salaries Review Body

Daniel Gale/Shutterstock.com
The FDA gave oral evidence to the Senior Salaries Review Body (SSRB) on 25 February, calling for the SSRB to recommend the government sets a pay bill increase for 2021.
Giving evidence, General Secretary Dave Penman and Assistant General Secretary Lucille Thirlby also called for the implementation of pay progression, urgent reform of performance management processes and outcomes, and action to tackle excessive working hours and workload.
In a message to members in the Senior Civil Service, Thirlby said: “There continues to be no real change in Senior Civil Service pay nor have the fundamental issues and challenges identified in successive SSRB reports been addressed.
“We remain extremely concerned that we are at a tipping point for the SCS, particularly in light of the lack of a business case or financial response by government to the critical pay issues.”
Writing for Civil Service World, Thirlby further criticised the lack of progress SCS pay reform: “Two years ago, I described the pace of change as glacial, but today I think a better gauge of speed would be the rotation of Venus – the only planet in the solar system where a day lasts longer than a year.”
She went on to argue that the government “know the problem, they know the solution, but they lack the political ambition to solve it.”
Related News
-
Under significant pressure: Interview with Director of Public Prosecutions
Tom Nathan speaks to Crown Prosecution Service Director of Public Prosecutions Stephen Parkinson about CPS’s handling of riots, the importance of impartiality and his plan to help reduce unmanageable prosecutor caseloads.
-
Changing the culture
HM Chief Inspector Sir Martyn Oliver sat down for an ‘in conversation’ event with FDA General Secretary Dave Penman, discussing the pace of change in Ofsted, challenging perceptions and tackling the long hours culture in Education.
-
Hybrid working: Led by evidence, not headlines
Tom Nathan shares the findings and recommendations of the FDA’s recent report on ‘The future of office working in the civil service’.